オステオゲネシス・インパーフェクトの小児における最初のネリドロネート注入後の急性相反応: 65人の患者のアンケートデータに基づく分析
Felicitas Haselwarter1, Stefanie Stasek2, Kristina Eva Rehberg3
1Department of Pediatrics, Children's Hospital, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
Paediatric drugs
|February 15, 2026
まとめ
発熱と骨格の痛みは,小児オステオゲネシス・インパーフェクト (OI) 患者における最初のネリドロネート注入後の一般的な急性相反応です. これらの副作用は,一般的に自己緩和であり,適切な痛み管理によって数日以内に改善します.
科学分野:
- 小児薬理学 小児薬理学
- 骨代謝障害 骨代謝障害 骨代謝障害について
- 臨床試験の方法論 臨床試験の方法論
背景:
- ビスホスフォネートは,小児性骨変生不完全症 (OI) の標準治療法である.
- 小児におけるネリドロネート初投与後の急性相反応 (APR) に関するデータは限られている.
研究 の 目的:
- 小児OI患者における最初の静脈内注射ネリドロネート輸液後のAPRの発生率,特徴,および重症度を評価する.
- この集団における最初のネリドロナート治療の安全性と耐性を評価する.
主な方法:
- 65人のビスホスフォナート投与前の小児性OI患者は,体重調整による静脈内ネリドロネート投与を受けた.
- 両親は標準化されたアンケートを使用して,発熱や骨格の痛みなどの副作用を報告しました.
- データ収集は,短期間の入院中に発生しました.
主要な成果:
- ネリドロネートは,一般的には,重度の有害事象なしによく耐えました.
- 40%の患者が一時的な発熱を経験しました (12-24時間発症,1〜2日解消).
- 40%が新しい骨格の痛みを報告し,60%が重度な痛みを経験したが,4日以内に改善した.
結論:
- 発熱と骨格の痛みは,小児OIにおける最初のネリドロネート注入の一般的な,しかし自己限定的な副作用です.
- 効果的な疼痛管理と介護者教育は,治療の遵守と患者の快適さにとって不可欠です.
さらに関連する動画
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.9K
13:44Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
Published on: December 9, 2022
4.5K
関連する概念動画
01:15Phase I Reactions: Hydrolytic Reactions
722
Hydrolysis, a cornerstone of phase I biotransformation reactions, uses water to cleave chemical bonds. This process is pivotal in drug metabolism, generating more polar metabolites that can be easily excreted.
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
722
01:24Phase II Reactions: Acetylation Reactions
864
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
864
01:27Phase I Reactions: Reductive Reactions
640
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
640
01:17Phase II Reactions: Methylation Reactions
768
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
768
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
390
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
390
01:24Phase II Reactions: Glucuronidation
1.8K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.8K